Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Prothena Corp (PRTA)

Prothena Corp (PRTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,196,430
  • Shares Outstanding, K 44,176
  • Annual Sales, $ 850 K
  • Annual Income, $ -111,140 K
  • 60-Month Beta 1.58
  • Price/Sales 2,731.35
  • Price/Cash Flow N/A
  • Price/Book 8.22
Trade PRTA with:

Options Overview

Details
  • Implied Volatility 85.67%
  • Historical Volatility 71.90%
  • IV Percentile 37%
  • IV Rank 31.18%
  • IV High 165.94% on 12/11/20
  • IV Low 49.30% on 01/27/21
  • Put/Call Vol Ratio 1.23
  • Today's Volume 89
  • Volume Avg (30-Day) 353
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 6,177
  • Open Int (30-Day) 6,037

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.56
  • Number of Estimates 4
  • High Estimate 0.71
  • Low Estimate 0.46
  • Prior Year -0.66
  • Growth Rate Est. (year over year) +184.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.09 +10.27%
on 07/27/21
67.08 -25.88%
on 07/09/21
+1.21 (+2.49%)
since 06/29/21
3-Month
21.30 +133.43%
on 05/14/21
67.08 -25.88%
on 07/09/21
+22.87 (+85.18%)
since 04/29/21
52-Week
9.67 +414.17%
on 09/29/20
67.08 -25.88%
on 07/09/21
+37.18 (+296.49%)
since 07/29/20

Most Recent Stories

More News
Prothena to Report Second Quarter 2021 Financial Results on August 5th

DUBLIN, Ireland, July 29, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein...

PRTA : 48.81 (-1.83%)
Prothena Presents New Data from Robust Alzheimer's Portfolio at the Alzheimer's Association International Conference 2021

- Late-breaking PRX012 poster highlights significant ex vivo clearance of both pyroglutamate-modified and -unmodified AB plaque from AD brain at concentrations expected to be reached in CNS with subcutaneous...

PRTA : 48.81 (-1.83%)
Prothena to Present Data from Two of its Alzheimer's Disease Programs at the Alzheimer's Association International Conference 2021

DUBLIN, Ireland, July 20, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein...

PRTA : 48.81 (-1.83%)
VRTX vs. PRTA: Which Stock Should Value Investors Buy Now?

VRTX vs. PRTA: Which Stock Is the Better Value Option?

VRTX : 197.82 (-1.28%)
PRTA : 48.81 (-1.83%)
Prothena Reaches Analyst Target Price

In recent trading, shares of Prothena Corp plc have crossed above the average analyst 12-month target price of $53.25, changing hands for $53.62/share. When a stock reaches the target an analyst has...

PRTA : 48.81 (-1.83%)
Biotech Stock Roundup: BIIB & PRTA Provide Updates, CLDX Up on Positive Data & More

The biotech sector was in focus last week on key updates form Biogen (BIIB) and Prothena (PRTA).

BIIB : 329.60 (+0.13%)
NVO : 92.59 (+1.34%)
AMGN : 242.44 (-0.01%)
CLDX : 44.16 (-0.81%)
PRTA : 48.81 (-1.83%)
SGTX : 5.41 (+2.27%)
Prothena (PRTA) to Sell ATTR Amyloidosis Program to Novo Nordisk

Prothena (PRTA) announces an agreement to sell its clinical-stage antibody, PRX004, and the broader ATTR amyloidosis program for $1.2 billion to Novo Nordisk.

BIIB : 329.60 (+0.13%)
RHHBY : 47.7600 (+0.25%)
NVO : 92.59 (+1.34%)
PRTA : 48.81 (-1.83%)
Thinking about trading options or stock in Celldex Therapeutics, Tesla, Prothena Corp, Microsoft, or Annovis Bio?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLDX, TSLA, PRTA, MSFT, and ANVS.

CLDX : 44.16 (-0.81%)
MSFT : 284.83 (-0.58%)
PRTA : 48.81 (-1.83%)
TSLA : 671.16 (-0.91%)
ANVS : 35.86 (-17.56%)
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena's ATTR Amyloidosis Programme

- Prothena is eligible to receive development and sales milestone payments totalling up to 1.2 billion US dollars, including 100 million dollars in upfront and near-term clinical milestone payments

NVO : 92.59 (+1.34%)
PRTA : 48.81 (-1.83%)
Strength Seen in Prothena (PRTA): Can Its 7.3% Jump Turn into More Strength?

Prothena (PRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

PRTA : 48.81 (-1.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Prothena Corporation plc is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies for disease-causing proteins. The Company is developing the following programs: NEOD001 for Amyloidosis, NEOD002 for Parkinson's disease, MCAM for Inflammatory disease and...

See More

Key Turning Points

3rd Resistance Point 56.73
2nd Resistance Point 55.21
1st Resistance Point 52.47
Last Price 48.81
1st Support Level 48.21
2nd Support Level 46.69
3rd Support Level 43.95

See More

52-Week High 67.08
Last Price 48.81
Fibonacci 61.8% 45.15
Fibonacci 50% 38.37
Fibonacci 38.2% 31.60
52-Week Low 9.67

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar